Held in Chicago, ACC 2025 is the premier event for exploring breakthroughs in cardiovascular research. Attendees will benefit from high-impact sessions, hands-on workshops, and networking opportunities. Our team will share key insights and discuss initiatives aimed at addressing challenges in heart health. Whether you’re looking to expand your research capabilities or collaborate on innovative treatments, we’re eager to connect with you.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
